Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous Contepo to Treat Complicated Urinary Tract Infections DUBLIN, Ireland, Nov. 01, 2018 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the research and development of innovative anti-infective agents to treat serious infections, announced […]Continue Reading ...
Screening Food and Drug Administration (FDA)-approved compounds for their ability to stop cancer growth in the lab led to the finding that the drug flunarizine can slow down the growth of triple-negative breast cancer in an animal model of the disease. Led by researchers at Baylor College of Medicine and the National Taiwan University College […]Continue Reading ...
The siren call of addictive drugs can be hard to resist, and returning to the environment where drugs were previously taken can make resistance that much harder. However, addicts who exercise appear to be less vulnerable to the impact of these environmental cues. Now, research with mice suggests that exercise might strengthen a drug user’s […]Continue Reading ...
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson’s disease psychosis (PDP)—a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions—researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC […]Continue Reading ...
Harmless at the low intensities routinely used for imaging bodily tissues, high-intensity focused ultrasound is approved for the ablation, or deliberate destruction, of certain tissues, including portions of a central brain structure called the thalamus to treat the condition known as essential tremor. For the new study, “we turned down the dials” on the ultrasound […]Continue Reading ...
This undated product image provided by Genentech shows a box for Xofluza, a pill for shortening the duration and easing symptoms of the flu. U.S. health regulators have approved the first new type of flu drug in two decades. The approval on Wednesday, Oct. 24, 2018, of Roche’s Xofluza comes ahead of this winter’s flu […]Continue Reading ...
CAMBRIDGE and NOTTINGHAM, UK, 5th November 2018 – Optibrium™, a developer of software for drug discovery, today announced it had entered into a collaboration with the University of Nottingham, a pioneering research institution and university. Optibrium’s StarDrop™ software will be available to a number of 4th year MSci Chemistry project students at the University of […]Continue Reading ...
Imagine a safe, painless, noninvasive way of delivering a drug to within a few millimeters (about an eighth of an inch, roughly the thickness of a stack of two pennies) of exactly the right spot in a person’s brain, and only there — and just for as long as you want the drug to be […]Continue Reading ...
A new antibiotic hailed as the “last line of defense” in the battle against drug-resistant superbugs such as MSRA and VRE is taking the next step in development thanks to a UK Government grant of almost £500,000. Over the next year scientists will develop a catalogue of simplified synthetic versions of a naturally-occurring antibiotic called […]Continue Reading ...
Credit: CC0 Public Domain Researchers from The University of Western Australia, King Edward Memorial Hospital and Curtin University are investigating whether an old drug could be used to help very sick premature babies. In a study published today in the British Journal of Clinical Pharmacology the researchers examine the use of a drug called pentoxifylline […]Continue Reading ...
Kevin Schulman, MD, MBA, has devoted his career to explaining the complexities of the U.S. health system and to teaching clinicians and business school students about the economics of medicine. Last summer, he joined Stanford Medicine’s Clinical Excellence Research Center (CERC), which aims to design and evaluate innovations that “reduce the cost of great care,” […]Continue Reading ...
I would imagine that as the Pharmaceutical industry moved from a small scale, almost cottage industry, approach to screening compounds, many people would suggest that this was driven by improvements in methodology related to liquid handling and miniaturization amongst many other hardware related developments. While that represents a truism, all of these technological breakthroughs needed […]Continue Reading ...
The new findings “will absolutely have the potential to change the way we practice,” said Dr. Nisha Jhalani of … Columbia University Irving Medical Center.Continue Reading ...
dolutegravir and lamivudine Treatment for HIV Infection ViiV Healthcare Submits New Drug Application to FDA for Single-Tablet, Two-Drug Regimen of Dolutegravir and Lamivudine for Treatment of HIV London – 18 October 2018 ViiV Healthcare today announced it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for a single-tablet, […]Continue Reading ...
Treatment for Dry Eye Disease Kala Pharmaceuticals Submits New Drug Application to U.S. Food and Drug Administration for KPI-121 0.25% for Dry Eye Disease WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 16, 2018– Kala Pharmaceuticals, Inc. (Kala) (NASDAQ:KALA), today announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for […]Continue Reading ...
- Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous Contepo to Treat Complicated Urinary Tract Infections
- Beating breast cancer only to die of opioid use – a sad Appalachian story
- Workplace bullying or violence linked to higher risk of cardiovascular problems
- Changes in Risk Indicators of MetS Severity Tied to T2DM Risk
- ‘Game-changing’ skin sensor could improve life for a million hydrocephalus patients
- Alcohol ads on social media sites with pro-drinking comments increase desire to drink
- Neural networks could replace marker genes in RNA sequencing
- Obese adolescents feel less food enjoyment than those with normal weight, study reveals
- Goodbye ‘Gluten-Free’? Celiac Disease Vaccine May Make It Possible
- Skin ages when the main cells in the dermis lose their identity and function
- Rainforest vine compound makes pancreatic cancer cells susceptible to nutrient starvation
- A new mechanism in the control of inflammation
- Age-related decline in abstract reasoning ability predicts depressive symptoms over time
- Scientists succeed in increasing stability, biocompatibility of light-transducing nanoparticles
- Sugar, a ‘sweet’ tool to understand brain injuries
- Pharmacist-Led Effort Cuts Inappropriate Rx in Older Adults
- Novel discovery could lead to new cancer, autoimmune disease therapy
- AHA and ADA launch new initiative to help people with type 2 diabetes reduce heart disease risk
- Balanced production of pro and anti-inflammatory cytokines at two years of age protects against malaria
- New pharmacological agent shows promise for prevention of heart rhythm disorders